VANDERTIE MICHELLE L
Insider CIK 1701690 · CNAT Vice President, Finance
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CNAT Conatus Pharmaceuticals In | D To issuer deriv | 2019-08-01 | 2019-08-01 | 20,000 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2019-08-01 | 2019-08-01 | 86,375 | — | $0 | 86,375 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | D To issuer deriv | 2019-08-01 | 2019-08-01 | 15,000 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | D To issuer deriv | 2019-08-01 | 2019-08-01 | 15,000 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | D To issuer deriv | 2019-08-01 | 2019-08-01 | 50,000 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | D To issuer deriv | 2019-08-01 | 2019-08-01 | 16,000 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | D To issuer deriv | 2019-08-01 | 2019-08-01 | 23,000 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | D To issuer deriv | 2019-08-01 | 2019-08-01 | 3,750 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | D To issuer deriv | 2019-08-01 | 2019-08-01 | 15,000 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | D To issuer deriv | 2019-08-01 | 2019-08-01 | 15,000 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2019-02-07 | 2019-02-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2018-02-04 | 2018-02-05 | 16,000 | — | $0 | 16,000 | SEC↗ |